Reduced ATR Signaling Contributes to Endothelial Dysfunction After Preeclampsia.

Schwartz KS, Sun M, Jalal DI, Santillan MK, Stanhewicz AE. Reduced ATR Signaling Contributes to Endothelial Dysfunction After Preeclampsia. Hypertension (Dallas, Tex. : 1979). 2024 Dec 26 DOI: 10.1161/HYPERTENSIONAHA.124.24098.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.    Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions

Search for Abstract from PubMed

---

Abstract:

BACKGROUND: Women who had preeclampsia (a history of preeclampsia) have a > 4-fold risk of developing cardiovascular disease compared with women who had an uncomplicated pregnancy (history of healthy pregnancy). Despite the remission of clinical symptoms after pregnancy, vascular endothelial dysfunction persists postpartum, mediated in part by exaggerated Ang II (angiotensin II)-mediated constriction. However, the role of vasodilatory ATRs (Ang II type 2 receptors) in this dysfunction is unknown. We examined the functional role of ATR in the microvasculature postpartum and whether acute activation of ATR improves microvascular endothelial function after preeclampsia. METHODS: Overall, 24 women (n = 12/group) participated. We measured cutaneous vascular conductance responses to (1) graded infusion of compound 21 (ATR agonist; 10-10M) alone or with NG-nitro-l-arginine methyl ester (NO synthase inhibitor; 15 mM) and (2) a standardized local heating protocol in control and 10M compound 21-treated sites. Expression of Ang II receptor subtypes I and II in biopsied venous endothelial cells was quantified using immunofluorescence. RESULTS: ATR-mediated dilation ( < 0.01) and the NO-dependent contribution ( = 0.003) of this response were reduced in women with a history of preeclampsia. Endothelial ATR expression was lower in women with a history of preeclampsia ( < 0.01), but there were no differences in endothelial ATR (Ang II type 1 receptor) expression ( > 0.05). Acute activation of ATR during local heating improved endothelium ( < 0.01) and NO-dependent ( < 0.01) dilation in women with a history of preeclampsia but had no effect in women with a history of healthy pregnancy (both > 0.05). CONCLUSIONS: Reductions in ATR-mediated dilation contribute to attenuated or impaired endothelial function in women who had a pregnancy complicated by preeclampsia. Furthermore, ATR activation may improve endothelial function through NO-dependent mechanisms in otherwise healthy women who had preeclampsia before the onset of cardiovascular disease. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT05937841.